RE:March 31, 2019Trial was supposed to start 2016, new plant transition supposed to be done Q1 2017 (trial planned to start before the new plant). Both are extremely late. Sorry to burst your bubble but the is not some master plan to greatly delay both projects because management is into numerology.
digitel wrote: If I was running a clinical trial I would want to use the product that I would be going to market with. That is, I would want to use beta glucan from a fully certified plant and PGX beta glucan from a large-scale production run. Is it any coincidence that the clinical trial start date is one day after March 31, 2019?
"In order to comply with current customer risk mitigation requirements and to further assess the potential of large-scale production of PGX dried beta glucan, we expect to keep operational two manufacturing sites until at least March 31, 2019."
Read more at https://stockhouse.com/news/press-releases/2018/11/19/ceapro-inc-announces-completion-of-successful-audits-by-major-customers#ewV5PPWFA7vb4FWD.99